Drugs / Procaine
Procaine
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | RAVOCAINE AND NOVOCAIN W/ NEO-COBEFRIN | — | 1952-09-19 | fda.gov ↗ |
Trials 5 · a red edge is where a trial was stopped
195119521953195419551956195719581959196019611962196319641965196619671968196919701971197219731974197519761977197819791980198119821983198419851986198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT00299338 | Sep 1997 → Sep 2001 | HIV infectious disease | Samaritan Pharmaceuticals, Inc | Completed | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT00299897 | Mar 2006 → ? | HIV infectious disease | Samaritan Pharmaceuticals, Inc | Unknown | No outcome recorded |
| Phase 2 | NCT00113412 | May 2005 → ? | HIV infectious disease | Samaritan Pharmaceuticals, Inc | Unknown | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT06717724 | Feb → Jun 2024 | osteoarthritis | Sf Luca Chronic Disease Hospital | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT01845532 | Apr → Nov 2013 | leiomyoma | Yonsei University | Completed | No outcome recorded |
Also used as a comparator or background therapy in 5 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT02735317 Comparator | Apr 2016 → Jun 2017 | nasopharyngeal neoplasm, stomatitis | Yun-fei Xia | Unknown | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT03838068 Background | Jan 2017 → Dec 2018 | exposure, dental pulp | Gihan M Abuelniel ,PhD | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT06425978 Background | May 2024 → May 2026 overdue | — | Fundacion Dexeus | Recruiting | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT06617065 Background | Sep 2024 → Jan 2025 overdue | chronic pain syndrome | The Seekers Centre | Active not recruiting | No outcome recorded |
| — | NCT02726620 Background | Jan → Dec 2017 | hypotensive disorder | Vanderbilt University Medical Center | Completed | No outcome recorded |
Evidence & citations 26 cited values
Every value below carries the sentence it was read from. 11 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Procaine | “Solutions contain either 0.3% Ropivacaine, 1% Procaine, 0.5% Lidocaine, 0.25% Bupivacaine, or a mixture of 0.25% Bupivacaine and 2% Lidocaine in a 9:1 ratio.” NCT06617065 ↗7“Trigger point injection with 25G needle on the shoulder before surgery(0.5% procaine, 0.25\~0.5% lidocaine, 0.125% bupivacaine)” NCT01845532 ↗ “A Pharmacokinetic and Safety Study of Procaine HCl in HIV-1 Infected Patients” NCT00299338 ↗ “procaine 25 mg/g + lidocaine 25 mg/g (Emla 5% cream)” NCT06425978 ↗ |
| Known as | Anestil | ChEMBL registry synonym — accepted as the source's own label CHEMBL569 ↗ |
| Known as | Enpro | ChEMBL registry synonym — accepted as the source's own label CHEMBL569 ↗ |
| Known as | Gero | ChEMBL registry synonym — accepted as the source's own label CHEMBL569 ↗ |
| Known as | Jenacaine | ChEMBL registry synonym — accepted as the source's own label CHEMBL569 ↗ |
| Known as | Medaject | ChEMBL registry synonym — accepted as the source's own label CHEMBL569 ↗ |
| Known as | Naucaine | ChEMBL registry synonym — accepted as the source's own label CHEMBL569 ↗ |
| Known as | Neocaine | ChEMBL registry synonym — accepted as the source's own label CHEMBL569 ↗ |
| Known as | Novocain | ChEMBL registry synonym — accepted as the source's own label CHEMBL569 ↗ |
| Known as | NSC-169497 | ChEMBL registry synonym — accepted as the source's own label CHEMBL569 ↗ |
| Known as | NSC-757280 | ChEMBL registry synonym — accepted as the source's own label CHEMBL569 ↗ |
| Known as | Omnicain | ChEMBL registry synonym — accepted as the source's own label CHEMBL569 ↗ |
| Known as | Pasconeural n | ChEMBL registry synonym — accepted as the source's own label CHEMBL569 ↗ |
| Known as | Planocaine | ChEMBL registry synonym — accepted as the source's own label CHEMBL569 ↗ |
| Known as | Procaina | ChEMBL registry synonym — accepted as the source's own label CHEMBL569 ↗ |
| Known as | Procaine hcl | ChEMBL registry synonym — accepted as the source's own label CHEMBL569 ↗ |
| Known as | PROCAINE HYDROCHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL569 ↗ |
| Known as | Procaine hydrochloride component of achromycin | ChEMBL registry synonym — accepted as the source's own label CHEMBL569 ↗ |
| Known as | Procaine hydrochloride component of cardioplegin | ChEMBL registry synonym — accepted as the source's own label CHEMBL569 ↗ |
| Known as | Procaini hydrochloridum | ChEMBL registry synonym — accepted as the source's own label CHEMBL569 ↗ |
| Known as | Rocain | ChEMBL registry synonym — accepted as the source's own label CHEMBL569 ↗ |
| Known as | Solution of novocain | ChEMBL registry synonym — accepted as the source's own label CHEMBL569 ↗ |
| Known as | SP01A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00113412 ↗ |
| Known as | Syntocain | ChEMBL registry synonym — accepted as the source's own label CHEMBL569 ↗ |
| Modality | Small molecule | — CHEMBL569 ↗ |
| Route | Oral | “orally administered SP01A” NCT00113412 ↗ |